Sutro is a California-based biopharmaceutical firm that researches and develops antibody protein sequencing and novel therapeutics for the treatment of cancer.
$85.4M
May 23, 2018
-
Dicerna is a Massachusetts-based biotechnology company that develops and commercializes RNAi therapies for the treatment of cardiometabolic and complement-mediated diseases.
$70M
Mar 29, 2017
-
Collegium is a Massachusetts-based specialty pharmaceutical company that develops and commercializes novel therapeutics for the treatment of serious medical conditions.
$50M
Mar 09, 2015
-
Advion is a manufacturer and supplier of mass spectrometers and analytics systems for life science and pharmaceutical sectors.
$1.5M
Jun 16, 2014
-
Proteon is a biopharmaceutical company that develops and commercializes therapeutics to the patients with kidney and vascular diseases.
$45M
May 12, 2014
-
Frequently Asked Questions about Skyline Ventures
What is Skyline Ventures investing in?
Skyline Ventures has invested in 27 companies including Sutro Biopharma, Dicerna and Collegium
What company did Skyline Ventures invest in?
Skyline Ventures invested in a total 27 companies including Sutro Biopharma, Dicerna and Collegium
What are the top 5 investments by Skyline Ventures?
The top companies in which Skyline Ventures invested are Sutro Biopharma, Dicerna, Collegium, Advion and Proteon
